It is exciting to see CSL Seqirus brand new, world-class vaccine and antivenom manufacturing facility in Melbourne coming to life. Members of the Australian Technical Advisory Group on Immunisation \(ATAGI\) recently toured the site to gain a better understanding of the facility's scale, the anticipated seasonal operations, and how CSL Seqirus would respond in the event of an influenza pandemic. Joining them were representatives from the Department of Health, Disability and Ageing, who organized the tour as part of ATAGI’s industry engagement activities. Learn more about CSL Seqirus here: https://bit.ly/4kUJ9vt #CSL #CSLSeqirus #CSLManufacturing #Manufacturing #Melbourne #ATAGI
Did you know? CSL is investigating a potential treatment to improve the health of people living with end-stage kidney disease (ESKD).
ESKD patients face an increased risk of cardiac events, like heart attacks and strokes.
CSL's 2025 Half Year Financial Results Click here for Full Information including Webcast Recording → | Would you like to read our 2024 Annual Report? Click here to view or download the Annual Report →
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and ProductsCSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and ProductsCSL Behring. Leading the Way in Treating Rare and Serious Diseases.
CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
More About CSL BehringCSL Seqirus. Global Vaccine Leader.
Through the power of innovation, our vision is to advance science to enhance public health worldwide. We stand on the front line with partners in public health discovering, developing, and delivering pioneering vaccine solutions to safeguard people and communities across the world.
More About CSL SeqirusCSL Vifor. Changing the Game in Iron Deficiency and Nephrology.
The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.
More About CSL ViforVita: Original Stories
'Vita' means life. It's also where we share the stories of biotech's promise to patients and public health.

Careers at CSL
We are committed to helping employees fulfill their career aspirations while working in a values-based culture. Are you next?
Pictured: CSL employees in Melbourne, Australia